v3.24.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Manufacturing Commitments and Contingencies

The following table summarizes manufacturing commitments and contingencies as of the period indicated (in thousands):

 

 

 

September 30, 2024

 

Molgramostim manufacturer:

 

 

 

Achievement of certain milestones related to validation of API and regulatory approval of
    molgramostim

 

$

650

 

Molgramostim nebulizer manufacturer:

 

 

 

Achievement of various development activities and regulatory approval of nebulizer utilized to administer molgramostim

 

 

559

 

Total manufacturing and other commitments and contingencies

 

$

1,209